To evaluate different methodologic approaches for HER-2/neu analysis, we performed Southern, Northern, Western blot and histochemical assay on 112 samples from 86 primary tumors and 26 synchronous axillary metastatic lymph nodes of patients affected by operable breast cancer. Simultaneous statistical analysis of data obtained with the four methods (31 samples) showed that Western blot detected a higher percentage of alterations than the other assays (Cochran and Victor tests, 0.01 < p < 0.05). The same result was emphasized by pair analysis (McNemar, p < 0.05), which evaluated the assay data two by two. Immunohistochemical evaluations were more in accord with immunoprecipitation data when performed on frozen or Bouin-fixed, paraffin-embedded tissues than on formalin-fixed, paraffin-embedded tissues.
Get full access to this article
View all access options for this article.
References
1.
AnbazhaganR., GelberR.D., BettelheimR., GoldhirschA., GustersonB.A.: Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer.Ann. Oncol., 2: 47–53, 1991.
2.
BergerM.S., LocherG.W., SaurerS., GullickW.J., WaterfieldM.D., GronerB., HynesN.E.: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.Cancer Res., 48: 1238–1243, 1988.
3.
FisherE.R., RedmondC., FisherB.: Histologic grading of breast cancer.Pathol. Annu. I, 15: 239–251, 1980.
4.
FontaineJ., TesserauxM., KleinV., BastertG., BlinN.: Gene amplification and expression of the neu (c-erbB-2) sequence in human mammary carcinoma.Oncology, 45: 360–363, 1988.
5.
HeintzN.H., LeslieK.O., RogersL.A., HowardP.L.: Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.Arch. Pathol. Lab. Med., 114: 160–163, 1990.
6.
KrausM.H., PopescuN.C., AmsbaughS.C., KingC.R.: Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.Embo J., 6: 605–610, 1987.
7.
LacroixH., IglehartJ.D., SkinnerM.A., KrausM.H.: Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.Oncogene, 4: 145–151, 1989.
8.
LupuR., ColomerR., ZugmaierG., SarupJ., ShepardM., SlamonD.J., LippmanM.E.: Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.Science, 249: 1552–1555, 1990.
9.
McGuireW.L.: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res.Treat., 10: 5–9, 1987.
10.
MolinaR., TandonA.K., AllredD.C., ClarkG.M., ChamnessG.C., GullickW.J., McGuireW.J.: HER-2/neu oncoprotein in breast cancer: a comparison of immunohistochemical and Western blot techniques.AACR Proceedings, 31: 170(Abs. n. 1012), 1990.
11.
SachsL.: Applied Statistics.A Handbook of Techniques.Springer Verlag, New York, 1982.
12.
SlamonD.J., ClarkG.M., WongS.G., LevinS.G., UllrichW.J., McGuireW.L.: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.Science, 235: 177–182, 1987.
13.
SlamonD.J., GodolphinW., JonesL.A., HoltJ.A., WongS.G., KeithD.E., LevinW.J., StuartS.G., UdoveJ., UllrichA., PressM.F.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.Science, 244: 707–712, 1989.
14.
SuenT.-C., HungM.-C.: Multiple cis- and trans-acting elements involved in regulation of the neu gene.Mol. Cell. Biol., 10: 6306–6315, 1990.
15.
TavassoliM., QuirkeP., FarzanehF., LockN.J., MayneL.V., KirkhamN.: c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumor grade, in human breast carcinoma.Br. J. Cancer, 60: 505–510, 1989.
16.
Van de VijverM., Van de BersselaarR., DevileeP., CornelisseC., PeterseJ., NusseR.: Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.Mol. Cell. Biol., 7: 2019–2023, 1987.
17.
Van de VijverM.J., MooiW.J., WismanP., PeterseJ.L., NusseR.: Immunohistochemical detection of the neu protein in tissue section of human breast tumors with amplified neu DNA.Oncogene, 2: 175–178, 1988.
18.
Van de VijverM.J., PeterseJ.L., MooiW.J., WismanP., LomansJ., DalesioQ., NusseR.: Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.New. Engl. J. Med., 10: 1239–1245, 1988.
19.
VenterD.J., SangeevK., TuziN.L., GullickW.J., Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.Lancet, 2: 69–72, 1987.
20.
YamadaY., YoshimotoM., MurayamaY., MasajazuE., MoriS., YamamotoT., SuganoH., ToyoshimaK.: Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.Jpn. J. Cancer Res., 80: 1192–1198, 1989.
21.
ZhouD.J., AhujaH., ClineM.J.: Proto-oncogene abnormalities in human breast cancer: c-erbB-2 amplification does not correlate with recurrence of disease.Oncogene, 4: 105–108, 1989.
